Determination of accurate 19F chemical shift tensors with R-symmetry recoupling at high MAS frequencies (60-100 kHz)
- PMID: 35568013
- PMCID: PMC10280466
- DOI: 10.1016/j.jmr.2022.107227
Determination of accurate 19F chemical shift tensors with R-symmetry recoupling at high MAS frequencies (60-100 kHz)
Abstract
Fluorination is a versatile and valuable modification for numerous systems, and 19F NMR spectroscopy is the premier method for their structural characterization. 19F chemical shift anisotropy is a sensitive probe of structure and dynamics, even though 19F chemical shift tensors have been reported for only a handful of systems to date. Here, we explore γ-encoded R-symmetry based recoupling sequences for the determination of 19F chemical shift tensors in fully protonated organic solids at high, 60-100 kHz MAS frequencies. We show that the performance of 19F-RNCSA experiments improves with increasing MAS frequencies, and that 1H decoupling is required to determine accurate chemical shift tensor parameters. In addition, these sequences are tolerant to B1-field inhomogeneity making them suitable for a wide range of systems and experimental conditions.
Keywords: R-symmetry recoupling; chemical shift anisotropy; high-frequency (19)F MAS NMR.
Copyright © 2022 Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures
References
-
- Gakh YG, Gakh AA, Gronenborn AM, Fluorine as an NMR Probe for Structural Studies of Chemical and Biological Systems, Magn. Reson. Chem, 38 (2000) 551–558.
-
- Chen H, Viel S, Ziarelli F, Peng L, 19F NMR: A Valuable Tool for Studying Biological Events, Chem. Soc. Rev, 42 (2013) 7971–7982. - PubMed
-
- Zhou Y, Wang J, Gu Z, Wang S, Zhu W, Aceña JL, Soloshonok VA, Izawa K, Liu H, Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas, Chem. Rev, 116 (2016) 422–518. - PubMed
-
- Mei H, Han J, Fustero S, Medio-Simon M, Sedgwick DM, Santi C, Ruzziconi R, Soloshonok VA, Fluorine-Containing Drugs Approved by the FDA in 2018, Chem. Eur. J, 25 (2019) 11797–11819. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
